TEKLA CAPITAL MANAGEMENT LLC – Apellis Pharmaceuticals, Inc. Transaction History
TEKLA CAPITAL MANAGEMENT LLC portfolio value:
$18.17M
portfolio value
TEKLA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.77% | -46.11K shares | 4.05M | $68.3 | 266.07K |
| Q2 2022 | share | Increase | +59.43% | 116.37K shares | 4.16M | $45.22 | 312.19K |
| Q1 2022 | share | 0.00% | 0 shares | 692K | $50.81 | 195.82K | |
| Q4 2021 | share | 0.00% | 0 shares | 2.80M | $47.95 | 195.82K | |
| Q3 2021 | share | Increase | +28.37% | 43.28K shares | -3.18M | $32.96 | 195.82K |
| Q2 2021 | share | 0.00% | 0 shares | 3.09M | $63.2 | 152.53K | |
| Q1 2021 | share | Decrease | -29.39% | -63.47K shares | -5.81M | $42.91 | 152.53K |
| Q4 2020 | share | 0.00% | 0 shares | 5.83M | $57.2 | 216.01K | |
| Q3 2020 | share | Increase | +24.51% | 42.52K shares | 851K | $30.17 | 216.01K |
| Q2 2020 | share | 0.00% | 0 shares | 1.01M | $32.66 | 173.49K | |
| Q1 2020 | share | Increase | +32.44% | 42.49K shares | 637K | $26.79 | 173.49K |
| Q4 2019 | share | Increase | +32.61% | 32.21K shares | 1.63M | $30.62 | 130.99K |
| Q3 2019 | share | Increase | 0.00% | 98.78K shares | 2.38M | $24.09 | 98.78K |